Header container
Skip to search results Skip to search
Go to Public Health Scotland home page
Navigation container
  • Population health
  • Healthcare system
  • Resources and tools
  • Publications
  • About us
  • News
  • Contact us
Breadcrumb container
  1. Home
  2. Population health
  3. Health protection
  4. Infectious diseases
  5. COVID-19
  6. COVID-19 Research Repository
  7. Advanced search
Content container

Advanced search

Find research...

How to use the AND field
How to use the OR field
How to use the NOT field
Active filters
Filters added:
Authors:
Andrews, Nick  Remove
Clear the search filters Clear filters

Filter by topic
  • Coronavirus (COVID-19) (14)
  • Immunisation and screening (6)
  • Older people (1)

Filter by type
  • Journal article (14)

Filter by access rights
  • Open access (14)
Filter by publication date
Su Mo Tu We Th Fr Sa
Test
Su Mo Tu We Th Fr Sa
Test
Apply date filter
Browse by topic Browse by author Browse by publisher

Showing 14 results

  • Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024

    Author
    Nørgaard, Sarah K. ; Nielsen, Jens; Nordholm, Anne Christine; Richter, Lukas; Chalupka, Alena; Sierra, Natalia Bustos; Braeye, Toon; Athanasiadou, Maria; Lytras, Theodore; Denissov, Gleb and 42 others
    Source
    Eurosurveillance
    Type
    Journal article
    Published
    11 April 2024
  • Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis

    Author
    Phillips, Angela; Jiang, Y.; Walsh, D.; Andrews, Nick; Artama, M.; Clothier, H.; Cullen, L.A.; Deng, Lul Lojok; Escolano, S.; Gentile, A. and 17 others
    Source
    Vaccine
    Type
    Journal article
    Published
    06 October 2023
  • Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

    Author
    Liu, Xinxue; Munro, Alasdair P.S.; Wright, Annie; Feng, Shuo; Janani, Leila; Aley, Parvinder K.; Babbage, Gavin; Baker, Jonathan; Baxter, David; Bawa, Tanveer and 51 others
    Source
    Journal of infection
    Type
    Journal article
    Published
    20 April 2023
  • Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

    Author
    Shaw, Robert H.; Greenland, Melanie; Stuart, Arabella S.V.; Aley, Parvinder K.; Andrews, Nick; Cameron, Claire; Charlton, Sue; Clutterbuck, Elizabeth A.; Collins, Andrea M.; Darton, Thomas C. and 31 others
    Source
    Journal of Infection
    Type
    Journal article
    Published
    06 April 2023
  • Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

    Author
    Shaw, Robert H.; Liu, Xinxue; Stuart, Arabella S.V.; Greenland, Melanie; Aley, Parvinder K.; Andrews, Nick; Cameron, Claire; Charlton, Sue; Clutterbuck, Elizabeth A.; Collins, Andrea M. and 31 others
    Source
    The Lancet Respiratory Medicine
    Type
    Journal article
    Published
    09 June 2022
  • Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial

    Author
    Liu, Xinxue; Munro, Alasdair P.S.; Feng, Shuo; Janani, Leila; Aley, Parvinder K.; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna and 48 others
    Source
    Journal of Infection
    Type
    Journal article
    Published
    09 April 2022
  • Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

    Author
    Munro, Alasdair P.S.; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K.; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate and 297 others
    Source
    Lancet
    Type
    Journal article
    Published
    18 December 2021
  • Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

    Author
    Stuart, Arabella S.V.; Shaw, Robert H.; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K.; Andrews, Nick; Cameron, Claire; Charlton, Sue; Clutterbuck, Elizabeth A.; Collins, Andrea M. and 34 others
    Source
    The Lancet
    Type
    Journal article
    Published
    06 December 2021
  • Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021

    Author
    Meslé, Margaux M.I.; Brown, Jeremy S.; Mook, Piers; Hagan, José; Pastore, Roberta; Bundle, Nick; Spiteri, Gianfranco; Ravasi, Giovanni; Nicolay, Nathalie; Andrews, Nick and 18 others
    Source
    Eurosurveillance
    Type
    Journal article
    Published
    25 November 2021
  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

    Author
    Liu, Xinxue; Shaw, Robert H.; Stuart, Arabella S.V.; Greenland, Melanie; Aley, Parvinder K.; Andrews, Nick; Cameron, Claire; Charlton, Sue; Clutterbuck, Elizabeth A.; Collins, Andrea M. and 28 others
    Source
    The Lancet
    Type
    Journal article
    Published
    06 August 2021
First page of 2 Previous page Page 1 of 2 Page 2 of 2 Next page Last page of 2
Footer container

Follow Public Health Scotland Follow us on X (formerly Twitter) Follow us on Instagram Follow us on Linkedin Follow us on Facebook

Sign up to our newsletter

Copyright container
  • Accessibility statement
  • Freedom of Information
  • Terms and Conditions
  • Cookies
  • Privacy notice

© Public Health Scotland

OGL Logo
All content is available under the Open Government Licence v3.0, except where stated otherwise.

Cookie preferences

We use cookies on this website which are essential for it to work. We also use non-essential cookies to help us improve our websites which will be set only if you accept. Any data collected is anonymised. For more detailed information about the cookies we use, see our Cookies page.

Reject all

Accept all


Some cookies are classed as strictly necessary, as the website won’t work properly without them. They are essential to allow you to navigate our site and to make sure the core processes work. You may disable these by changing your browser settings, but this may affect how the website functions.


Other cookies are non-essential and are classed as performance cookies. They are used to collect information in aggregate about how visitors use our site. This data is used to make informed decisions on whether the site is meeting your needs, which leads us to making improvements. Non-essential cookies are used to store information about how you use the site and can be turned off.


Save and close